Nisa Investment Advisors
DTIL icon

Nisa Investment Advisors’s Precision BioSciences DTIL Stock Holding History

Nisa Investment Advisors’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11K Buy
+1,400
New +$9.85K ﹤0.01% 2435
2022
Q2 		– Sell
-93
Closed -$9K – 2402
2022
Q1 		$9K Buy
+93
New +$12.6K ﹤0.01% 2228

Other funds holding DTIL

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Nisa Investment Advisors's DTIL Position: Q2 2026 in Review

Nisa Investment Advisors opened a new position in Precision BioSciences (DTIL) in Q2 2026: 1,400 shares worth $11K. The stake represents ﹤0.01% of the portfolio and ranks #2435 among its holdings. This is a return to the name: Nisa Investment Advisors previously reported a position in DTIL as recently as Q1 2022.

Nisa Investment Advisors first reported a position in DTIL in Q1 2022 and has held it in 2 quarters since. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • Nisa Investment Advisors held 1,400 shares of Precision BioSciences worth $11K as of Q2 2026.
  • Precision BioSciences was a new Nisa Investment Advisors position in Q2 2026.
  • Precision BioSciences made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2435 holding.
  • Nisa Investment Advisors first reported a position in Precision BioSciences in Q1 2022 and has held it in 2 quarters since.
  • 95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.